Authors
Loading...
Experimental autoimmune model shows IL-10 improves outcomes in type 1 diabetes, suggesting new therapeutic approaches.
Kirsten C Refvik (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: